How to Watch ‘Interview With The Vampire’ Series Premiere For Free on Apple TV, Roku, Fire TV and Mobile – The Streamable

Posted on October 3, 2022 by Danzig

It wouldnt be Spooky Season without a new vampire show, and AMC is helping to bring back some of the most beloved vampiric characters of all time. Interview With The Vampire, a new adaptation of the classic Anne Rice novel, is coming to AMC on Sunday, Oct. 2 at 10 p.m. ET. Watch Louis and Lestat come together once again, in an epic story of love, blood, and the perils of immortality with a 5-Day Free Trial of DIRECTV STREAM.

Episodes will air simultaneously on AMC+. The first two episodes will debut on AMC+ on Oct. 2.

A sensuous, contemporary reinvention of Anne Rices revolutionary gothic novel, Interview with the Vampire follows Louis de Pointe du Lac (Jacob Anderson), Lestat de Lioncourt (Sam Reid), and Claudia (Bailey Bass) in an epic tale of romance, violence, and the pitfalls of immortality, as told to journalist Daniel Molloy (Eric Bogosian).

Chafing at the limitations of life as a Black man in 1900s New Orleans, Louis finds it impossible to resist the rakish Lestat de Lioncourts offer of the ultimate escape: joining him as his vampire companion. But Louis intoxicating new powers come with a violent price, and the introduction of Lestats newest fledgling, the child vampire Claudia, soon sets them on a decades-long path of revenge and atonement.

Interview With The Vampire has yet to debut, but is generating so much buzz that its already been picked up for a second season.

There are six major streaming providers that offer Live TV Streaming. Five of these providers allow you to watch Interview With The Vampire using iOS, Android, Roku, Apple TV, Fire TV, Chromecast, and Web. You can stream it with DIRECTV STREAM, fuboTV, Sling TV, Philo, and YouTube TV.

Here is the original post:
How to Watch 'Interview With The Vampire' Series Premiere For Free on Apple TV, Roku, Fire TV and Mobile - The Streamable

A Young Kobe Bryant Once Made 9 Players On The Court Cry While Playing In Italy: "The Other 9 Players Started Crying And Their Parents Started…

Posted on October 3, 2022 by Danzig

Kobe Bryant was one of the most competitive basketball players in the history of the sport, always looking for the smallest of advantages over his opponents in a game. That sort of instinct is required in the NBA, as the smallest margin of error for one player can lead to big results for another player. Kobe knew this better than anyone and spent his whole life honing his mentality.

Bryant spent the early years of life in Italy, as his father, Jellybean Bryant played professionally in the country after a few years in the NBA. Kobe learned about the game from his father and put his skills on display against other kids his age in Italy. This led to a young Bryant being racially abused and called a 'scuro', which means dark in Italian, as he made the 9 players he shared the court with cry.

He dribbled and shot and shot and dribbled and scored so many points scored the first ten points in his first game that the other nine players started crying and their parents started screaming to get this spoiled little scuro off the court." (h/t NY Post)

This was revealed in Mike Sielski's book 'The Rise Kobe Bryant and the Pursuit of Immortality'. Bryant would move back to the United States after his father retired from basketball, becoming one of the best high school players in Philadelphia and being drafted into the NBA before turning 18 years old.

Kobe Bryant was always going to have an edge over his opponents in Italy. Not only is basketball not the primary sport there, but he was also being personally taught by his father at that age. We all know the mentality that Kobe had, so he was going to use everything in his arsenal to prove a point.

His opponents were other kids who didn't take the game as seriously as him, so they were bound to be upset. Kobe's mentality served him well for the entirety of his NBA career, as the teachings of his 'Mamba Mentality' have become an aspirationaltarget for NBA players. Everybody wants to have Mamba Mentality on the court, and that credit goes entirely to Kobe.

Excerpt from:
A Young Kobe Bryant Once Made 9 Players On The Court Cry While Playing In Italy: "The Other 9 Players Started Crying And Their Parents Started...

Baijnath: The Himachal town that doesn’t celebrate Dussehra – Times of India

Posted on October 3, 2022 by Danzig

Some 50 km from Dharamshala in Himachal, lies a pretty town named Baijnath in the Kangra district of Himachal Pradesh. The town is mostly noted for being home to an ancient temple of Lord Shiva (Baijnath Temple), after which the place is named.

But thats not all; do you know, Baijnath is a rare place in India where Dussehra is not celebrated, and this is why.

Soon after getting his wishes fulfilled, Ravana requested Lord Shiva to come with him to Lanka. Therefore, the Goa converted himself into a shivalinga and asked him to carry it to Lanka. However, Shiva also warned him not to put the shivalinga down on the ground on his way and, if for some reason, he does that, Shiva will settle at that very spot forever.

Soon after quenching his thirst, Ravana felt the urge to answer nature's call. So he requested Ganesh to hold the shivalinga while he relieved himself. But, Lord Ganesha kept the linga on the ground and, as told by Shiva, the shivalinga settled at the same spot in the form of Ardhanarishwar (Lord Shiva in the form of half male and half female). The spot was in the modern day town of Baijnath, where Dussehra is not celebrated in respect of Ravana's devotion to Lord Shiva.

While the whole country burns the effigy of Ravana and his clan, Baijnath has no such ritual.

About Baijnath Temple

Legacy of Kain series revival teased by Crystal Dynamics in new survey – Niche Gamer

Posted on October 3, 2022 by Danzig

It seems that a Legacy of Kain revival is possibly being considered by Crystal Dynamics, if a new survey is anything to go by.

The new survey was posted by developer Crystal Dynamics, polling fans on what their favorite titles in the series are, how they rate each game, and even whether they prefer the eponymous Kain or his lieutenant, Raziel as a protagonist.

However further into the survey fans get a tantalizing question: what would they prefer the next game in the Legacy of Kain series to be? The options you can select include:

Its worth noting that the above four options in the survey are set to be put in order of which you prefer most so Crystal Dynamics is considering everything when it comes to reviving the beloved series.

The survey then goes on to ask which of the five main games in the series theyd like to see get a remake or remaster, and whether or not theyd like to see a story recap in these purported re-releases. It also asks what modern game most resembles what theyd expect a new Kain title would play like, and what media most resembles the tone of the series.

The survey also asks more intricate questions like what they enjoy most in vampire games, i.e. blood feeding, immortality, magic, and so on. Interestingly, the survey also asks which of the supporting characters are the players most favorite, and what other vampire games theyve enjoyed the most (aside from the Legacy of Kain series, of course).

Its very possible that the Embracer Group buyout of Crystal Dynamics will lead to a revival of the series, as the parent company and its subsidiaries have been bringing several IPs back from the dead with their seemingly endless cash.

Would you like to see a Legacy of Kain series revival? In what form and what kind of games would you like to see? Sound off in the comments below!

The rest is here:
Legacy of Kain series revival teased by Crystal Dynamics in new survey - Niche Gamer

Star Wars’ Darth Vader will ‘live forever’ after being given digital AI immortality – Daily Star

Posted on October 3, 2022 by Danzig

Darth Vader will feature in Star Wars films for years to come, thanks to an 'immortalising' AI technology.

James Earl Jones, the 91-year-old actor who has been the voice of Darth Vader since 1977, has reportedly agreed to have his voice synthesized by an AI so that Disney doesn't have to recast the role after he dies.

According to Vanity Fair, the aging actor agreed to let Ukrainian AI company Respeecher take past recordings of his voice and use it to create new lines for Darth Vader that sound "indistinguishable from the original speaker".

READ NEXT: Inside Harrison Ford and Carrie Fisher's saucy 3-month affair

The method was reportedly used during during the newly-released Obi-Wan Kenobi series over on Disney+.

It was used because the series needed to depict a younger Darth Vader between Star Wars Episode III and IV, and because Jones no longer wants to play the character at his age.

Jones has given the green light to archive recordings of him playing Darth Vader so that the AI company can continue to churn out convincing lines long after he's gone.

It marks yet another high-tech immortalisation of an iconic Star Wars character, after both Carrie Fisher and Peter Cushing reprised their roles in the series after their deaths.

An 'eerie' CGI version of Peter Cushing, complete with digitally reconstructed voice, appeared in Rogue One.

Meanwhile, Carrie Fisher was 'brought back' as Princess Leia in Star Wars: Rise of Skywalker, again using advanced CGI technology.

With an additional sequel trilogy reportedly planned for Star Wars, as well as a myriad of TV series and shorts coming out continually on Disney+, we could be watching artificial characters replace actors for years to come as Disney continues to milk the galaxy for all it's worth.

Pop the cork to unlock the health benefits of red wine – Lifestyle Asia India

Posted on October 3, 2022 by Danzig

Moderate wine consumption is believed to have several advantages. Health benefits of red wine aside, unwinding with a cold glass of the beverage after a hectic day is like a much-needed hug for the soul. Right from Biblical times, wine has been presented as a sacred elixir which is healing, soothing and even life-giving. This, probably, makes it one of the most loved alcoholic beverages worldwide. The benefits of red wine are thus something you should know about.

A glass of red wine is like a best friend we cant do without owing to its versatility. A reliable party companion, a key ingredient in your signature recipe, a therapist and a confidante drinking red wine can mean different things to different people.

However, knowing the right bottle of red is a form of art, which sommeliers spend decades mastering by unravelling the mystery behind this deep, richly textured magic potion. But in addition to its major cultural relevance, its also touted to have health benefits, while avoiding excessive drinking.

Making, ageing and preserving wine is an art which has been perfected for over 8,000 years. While there have been changes in the types of equipment used with innovative technology, the basic method remains true to its origin. Specially cultivated grapes go through around 12 steps before reaching your table in a rich, red, consumable form.

A special variety of black (or purple) grapes rich in anthocyanin gives red wine its signature red colour. They are harvested when perfectly ripe and prepared for fermentation. Harvesting grapes for wine is the primary step in winemaking as well as for cultivators who own some of the best vineyards.

Then, the grapes are taken to the winery where yeast is added to the fermentation process a crucial stage of red winemaking. This process is critical for the wines colour, texture and aroma. Different methods are employed to extract the flavours from grape skins and other fermenting elements.

The grapes are then transferred to a press. Making red wine is a little more complicated because the pressed grape liquid goes through fermentation once again while they are stored in barrels and containers of different types. The quality of red wine depends on how well it has been aged and rested.

Winemakers do a final blending of two or more grape liquids, which gives the wine a more nuanced taste. Each red wine type be it Shiraz, Merlot, Cabernet Sauvignon, Zinfandel or Pinot Noir gets its unique texture and flavour from such processes. The liquid is then filtered and bottled. At this stage, bottled wine is aged again in a cellar before it is ready to be consumed.

It is believed by some that moderate drinking of red wine should no longer be a guilty pleasure, as it has several health benefits.

Resveratrol, an antioxidant found in the skins of black grapes used to make red wine, might be linked to reducing heart diseases. It is touted that drinking red wine can reduce bad cholesterol and the subsequent formation of blood clots in the body.

A Science Direct report (2005) claims that this antioxidant does not directly reduce the risk of cardiovascular diseases but the resveratrol present in it may prevent damage to blood vessels along with another compound procyanidins found in the grapes. Reports studying the implication of red wine on cardiovascular health suggest that people who generally consume antioxidant-rich whole foods with a light to moderate quantity of red wine have decent heart health.

An NCBI report (2021) states that by drinking red wine in moderation, useful compounds are secreted in blood flow which in turn make positive changes in our bodys metabolic profile with an increase in fatty acids, cholesterol, branched-chain amino acids, ketone bodies, bacterial co-metabolites and cellular antioxidants. The report adds that drinking red wine might increase your longevity by seven percent.

Another red wine health benefit is associated with the improvement of gut bacteria in the body. A 2015 Medical News Today study states that resveratrol found in red wine is a natural phytoalexin, which encourages the formation of good gut bacteria which act like probiotics. The research is still ongoing to unlock the maximum health benefits of red wine on the gut.

This one is a bit of a paradox because excessive alcohol consumption is linked to an increase in depression. Still, studies show that moderate red wine consumption on a daily basis can help in beat stress and put you in a relaxed mood.

Resveratrol seems to be the magic ingredient found in red wine, as it is also linked to preventing cancer. Drinking red wine in moderation can unlock protective elements present in resveratrol, which work against the growth of cancer cells in the body. Though regular alcohol consumption raises breast cancer risk, red wine is an exception to this. Red wine has the opposite effect when consumed in moderation as reported by researchers from Cedars-Sinai Medical Center in Los Angeles in the Journal of Womens Health.

A BMJ medical report published in 2018 states that individuals who have never consumed alcohol, especially red wine, are at an increased risk of disorders including dementia and Alzheimers. One of the major health benefits of polyphenols, found in red wine, is that it has neuroprotective qualities. Thus, moderate red wine consumption might actually be helpful.

While sipping wine has been associated with wellness, in addition to relieving emotional stress, the key, as confirmed by research, is moderate red wine consumption. To get the most health benefits from this evergreen drink, doctors suggest that both men and women should limit their red wine consumption to two glasses per day. Additionally, individuals with a medical condition or seeking treatment for the same should consult their doctors before drinking red wine or any alcohol, as it can have counterproductive effects on their health.

Hero Image Credit: Kelsey Knight/Unsplash; Featured Image Credit: Rikkia Hughes/Unsplash

Peanuts: Best guide to learn health benefits, nutrition and side effects – PINKVILLA

Posted on October 3, 2022 by Danzig

Every person around the globe is aware of peanuts - crunchy and tiny nuts. These nuts or legumes make a mouth-watering side meal and come in handy whenever you are craving a delicious snack, especially during fasting and weight loss routine.

Peanuts are super rich in several minerals, micro and macro-nutrients, and vitamins, are highly affordable, and are a versatile ingredient - when compared to any other variety of nuts. Either raw or roasted, whatever form you choose to consume these tasty nuts, one thing is for sure - that you will end up with loads of health benefits, including strong heart health, beautiful skin, shiny hair, energy boost, and a good night's sleep.

Hence, this article. Today, we will talk about everything related to peanuts - from its definition, types, and nutritional facts to health benefits and also potential risks (if consumed in a heavy dose regularly).

Grab a handful of peanuts while you give this article a read. Let's start!

Peanuts are a type of legume that are surprisingly related to lentils, beans, and soy, and not to tree nuts.

Peanuts (Arachis hypogaea) originated in South America and are known by a variety of names, like earthnuts, groundnuts, and goobers.

The most popular type of peanut consumption is either raw (along with a pinch of tangy, salty powder) or in the form of peanut butter (both smooth and crunchy).

Yes, you read that right. Peanuts have a variety, as per the National Peanuts Board. There are four types of Peanuts -

With big kernels and premium characteristics, this type of peanut is known as a gourmet peanut. Due to their large size and pretty form, Virginia peanuts are best suited for snacking. This variety of peanuts is grown in Virginia, Carolinas, Texas, Florida, Oklahoma, Georgia, and New Mexico regions.

Runner peanuts are widely used to prepare peanut butter and other such confections. This type of peanut makes up 80% of the peanuts grown in the U.S.

With a slightly sweet flavor profile, Valencia peanuts make for all-natural peanut butter and an excellent boiled snack. This type of peanut makes up lesser than 1% of the peanuts grown in the U.S. and is mainly grown in the New Mexico and Texas regions.

The type of Peanuts with red skins and a nutty flavor profile is called Spanish peanuts. They are mainly consumed after roasting and have a slightly higher oil content, which adds depth to their overall nutty flavor. They are usually grown in New Mexico, Oklahoma, and Texas regions and are widely used in confections, candy, and peanut butter.

Peanuts are loaded with high-quality protein and healthy fats. Here is the nutrition profile for 3.5 ounces (100 grams) of raw Peanuts -

1. Calories (or Energy) = 567 kcal

2. Water content = 7%

3. Fat = 49.20 gm

4. Omega-3 = 0 gm

5. Omega-6 = 15.560 gm

6. Macronutrients:

7. Minerals:

8. Vitamins:

9. Fat:

Apart from these, Peanuts also contain a rich amount of biotin and copper - all of which are essential to reduce the risk of multiple ailments and maintain body metabolism.

Peanuts are versatile, flavorsome, and jam-packed with crucial nutrients, offering numerous health benefits, including supporting heart health, promoting muscle growth, losing weight, enhancing sexual function, etc. A plethora of health benefits of Peanuts as discussed below -

Consuming Peanuts every day in moderation helps those who are aiming to shed some extra kilos. Although Peanuts have a high-calorie level, they are all good fats. Add this to the high protein content, and Peanuts become great for weight loss by providing high satiety value. Not to forget that eating more protein reduces the level of Ghrelin, a-k-a, the hunger hormone, in your body. Thus, increasing the production of Peptide YY (a hormone which is responsible to make you feel full). Therefore, preventing you from binge eating.

Multiple studies have proven that consuming Peanuts tends to decrease the chances of heart diseases. Peanuts consist of nutrients that are crucial for having a healthy heart. These nuts contain copper, magnesium, protein, antioxidants (like Resveratrol), a healthy ratio of unsaturated and mono-unsaturated fats, and fiber that altogether help in reducing your bad cholesterol levels. Peanuts also contain antioxidants and amino acids that keep the inner lining of your arteries safe, thereby protecting your heart against heart problems like atherosclerosis. Also, as per a research published in the New England Journal of Medicine, a daily dose of these crunchy nuts reduces the risk of death from heart disease by 29%.

Peanuts consist of antioxidants (like Resveratrol) and mono-unsaturated fats that make your skin clear. These nutrients also wash away all the toxins from your body that make your skin appear dull, greasy, and lifeless. The antioxidant, Resveratrol, even delays the signs of aging, including fine lines, wrinkles, and dark spots. Additionally, this antioxidant is a scientifically proven cure for skin diseases like Eczema and Psoriasis.

Research shows that Vitamin E and Vitamin C present in the Peanuts protect your skin against the harsh UV rays of the Sun from causing any subsequent damage. Plus, the presence of Vitamin C also gives elasticity to your skin, making it look brighter, younger, and smoother.

To keep your brain healthy, active, and sharp, you obviously require rich nutrients like Vitamin B1, Folate, and Niacin. When you include Peanuts in your daily meal, your body tends to fuel up with these nutrients. And as a result, your brain becomes more active, healthy, and sharp. Vitamin B1 and Niacin also help to protect your brain against diseases like Alzheimers and age-related cognitive decline. Moreover, Peanuts are jam-packed with a bioactive antioxidant called Resveratrol, which improves verbal fluency and cognitive abilities in people. Also, Polyphenols present in Peanuts are called mood food that helps against cognitive and psychiatric disorders, which, in turn, keeps your brain healthy.

The requirement of protein necessary for the proper and healthy growth of children can be fulfilled by eating Peanuts on a daily basis. Peanuts are loaded with protein, making about 22% to 30% of their total calories. This protein helps in building muscle mass while promoting muscle growth and supporting bone health. Plus, adequate protein intake also helps to speed up any wound healing. Additionally, adding Peanut butter spread on toast or crackers makes a great and super tasty pre-workout or mid-day snack while adding to your total protein intake.

Aging in people causes the weakening of many bones present in your body. Therefore, before your bones start losing their agility and strength, you must focus on eating healthy and nutrient-rich food options like Peanuts. Plus, Peanuts are rich in phosphorus and manganese. These nutrients and other essential Vitamins that are present in Peanuts help to keep up and maintain the strength of your bones, thereby assisting you in your old age.

When it comes to the maintenance of your eye health, a few green leafy vegetables and Peanuts are considered the best food items that you should consume. The presence of Zinc in Peanuts helps your body to transfer Vitamin A, which is highly crucial for clear and healthy eyesight and vision. Also, the presence of Vitamin E in Peanuts helps to slow down cataract formation and any other age-related macular degeneration or illness.

Peanuts are super rich in an essential amino acid, Arginine, that has been studied extensively and thoroughly as a possible treatment and cure for erectile dysfunction. However, there is still more research required to understand if Arginine alone can help to treat erectile dysfunction. But, research analyses confirm that oral administration of this amino acid when combined with a herbal supplement, Pycnogenol, may help in the treatment of erectile dysfunction.

Peanuts are a great source of healthy fats that mostly come from Oleic acids, which are also found in olive oil. This particular acid present in the Peanuts truly helps to fight against inflammation and other free radicals in your body cells.

Since Peanuts have no sugar content, they are completely safe for all diabetic patients. Plus, these nuts are a rich source of vital nutrients and are truly delicious at the same time. Also, research shows that eating Peanuts (especially in the morning) can help you to keep a check on your blood sugar level throughout the day. And it may also prevent insulin spikes to some extent if and when you eat sugary foods. As per a research study by The American Medical Association, regular (and controlled) consumption of Peanuts actually strengthens your bodys natural ability to regulate and maintain its insulin levels against Type 2 diabetes.

Thorough researches have shown that consuming Peanuts can reduce the risk of cancer. Plus, Peanuts have an excellent amount of Vitamin E and protein that helps to lower the risk of cancer. Also, these legumes have a good content of antioxidants like Resveratrol, which further helps in preventing cancer by cutting off the blood supply to your growing cancer and restraining cancer cell growth.

Around 25% of adults suffer from gallstones - a disease caused by uncontrolled levels of bad cholesterol - every year. Since Peanuts control cholesterol levels, eating an adequate amount of Peanuts may reduce the risk of gallstones in adults as well as in children.

Peanuts are jam-packed with an amino acid, Arginine, that is converted into Nitric Oxide - a compound that helps to dilate your blood vessels to improve overall blood flow and circulation. Studies show that taking Arginine supplements may help in the treatment of mild to moderate erectile dysfunction, enhancing sexual function. Other test-tube studies have found that Arginine can also enhance libido, improve semen quality, and increase your overall testosterone levels. Additionally, Peanuts are a very good source of antioxidants like Resveratrol that have proven to support and enhance sexual health in men by improving erectile function and sperm quality. However, more research is still needed to determine if Peanuts specifically can affect sexual function.

Contrary to a popular belief (rather a myth), adding Peanuts or Peanut butter to your meal does not spike your blood sugar levels. Rather, having them alongside your meal high in GL (like a glass of juice or a savory bagel) may actually stabilize your blood sugar levels. That is probably the reason why the American Diabetes Association names Peanuts among the diabetes-friendly superfoods. Furthermore, the fiber content found in Peanuts also helps to lower your blood sugar levels. And these nuts also contain magnesium and several other healthy oils that play a vital role in managing, controlling, and balancing your blood sugar levels.

Eating Peanuts daily in an adequate amount is healthy and good, but overeating them obviously may backfire just like with any other food. However, aside from Peanut allergies, eating them has not been linked to many severe adverse effects. Still, below are some possible side effects of Peanuts that you should consider and know.

What 6 Over-50 Beauty Experts Do to Treat Their Own Skin – NewBeauty Magazine

Posted on October 3, 2022 by Danzig

New York dermatologist Doris Day, MD

Significant Changes:I increased hydration and added higher-gradepeptides.

Go-to Products:I am always testing products but ingredients Istick to include growth factors,antioxidants, resveratrol, retinol, niacinamide and hyaluronic acid. There are always new ingredients and formulas Im working on, right now Im looking at ones that help support and nourish a healthy skin biome.

Favorite Treatments:My go-to treatments include a Sofwave ultrasound skin tightening treatment twice a year, neuromodulator injections about three times a year and a little filler touch up once a year.

Best Advice:Sun protection every day. Youre never too old or too young to protect your skin. Also see a great dermatologist to make sure you have a plan to keep your skin healthy and beautiful. Finally, see a functional medicine doctor or gynecologist who specializes in hormone replacement. It will help preserve collagen in your skin, as well as reduce other risks of aging.

Continued here:
What 6 Over-50 Beauty Experts Do to Treat Their Own Skin - NewBeauty Magazine

Brad Pitt’s New Skin Care Line Inspired by Wine: What Experts Think – Healthline

Posted on October 3, 2022 by Danzig

Brad Pitt is getting a taste of the beauty industry with a new skin care line that promises to help people age like fine wine.

The new line, Le Domaine, is a joint effort between Pitt and organic wine growers the Perrin family. The products include creams and serums and cost between $80 to $385 and come in small bottles made of recycled glass made with re-purposed parts of wine barrels.

Le Domaine purports to have uncorked the secret to slowing aging with a pair of exclusive, patented active ingredients. The first, GSM10, is made, in part, from a marc from grenache seeds and syrah seeds. The lines website says these ingredients work to stop collagen destruction, have antioxidant properties, and balance the skin.

The second, ProGR3, is said to reduce visible signs of aging by using natural molecules found in plant extracts, vine cuttings, chamomile, and green tea.

Though the line touts graceful aging benefits, Pitt interestingly debunked the idea that you can stop the clock in an interview.

I dont want to be running from aging, Pitt said while discussing the line with Vogue. Its a concept we cant escape, and I would like to see our culture embracing it a bit more, talking about it in those terms.

Ultimately, Dr. Viktoryia Kazlouskaya, a dermatologist with Khrom Dermatology, Brooklyn, N.Y., says approaches to physical signs of aging are as varied as tastes in wine. Some feel young inside and want their appearance to match that. Others see lines and wrinkles as signs of a well-lived life, and others prefer a blend.

Either approach reflects the expression of the authentic self, as authenticity means different things for different people, Kazlouskaya says. There is no shame in a desire to match the inner energy with the outer, and anti-aging practices will stay with us for the years ahead.

But will Pitts new foray into beauty help people who want to slow the signs of aging? Heres what dermatologists and researchers say.

Pitts active ingredients are new. But some of the components of them, like the syrah seeds, are inspired by wine.

Wine, particularly red, has a reputation for providing some health benefits, including to the skin. But the recent evidence is contradictory.

In fact, research from 2019 indicated that drinking wine could increase signs of facial aging, including undereye puffiness. However, the plant compound resveratrol, found in red wine, may help fight cell damage, an older 2010 review suggested.

But what about the topical use of some of these ingredients?

Lets start with those found in GSM10. Though no peer-reviewed studies exist on it, one expert says the gape seed extract may have some promise.

Grape seeds are known to be rich in polyphenols which are molecules that have antioxidant and anti-inflammatory properties, says Dr. Emily Wood, a board certified dermatologist, at Westlake Dermatology in Austin.

A 2020 review pointed to research that grapeseed extracts had anti-inflammatory properties and might have benefits that support aging gracefully. An older 2011 study of mice indicated that grape seed extract might reduce sun damage, a key trigger for premature aging.

Similarly, the components of ProGR3 do have some research behind them.

A pair of smaller studies one from 2005 and another from 2013 suggest green tea extract could slow skin aging.

A 2010 study indicated chamomile oil application could reduce atopic dermatitis in mice, while one from 2018 suggested application could aid wound healing. Though neither study on chamomile mentioned aging, one expert believes that, like green tea, the properties suggest it could help.

Both green tea and chamomile address signs of aging topically and when ingested, says Dr. Reid Maclellan, the founder and CEO of Cortina, adjunct Faculty at Harvard Medical School, and director of Proactive Dermatology Group. Both teas are antioxidant-rich and within, have a biological compound called polyphenols which work to destroy free radicals and slow the progression of aging.

Maclellan says the decision to use vine cuttings may be because of the research behind resveratrol. Research, like a 2019 review, suggests it has antioxidant properties to slow photoaging and protect against oxidative damage, such as from UV radiation.

Could all of these components, combined, team up to fight the signs of aging? The jury is out.

The key question is whether or not these extracts are actually permeating the epidermis due to the fact that polyphenols are hydrophilic, and the top layer of the skin has a high lipid content, says Wood. Think of the simple kitchen experiment of mixing oil and water together. Similar principles are at play when we think of drug delivery to the skin. The vehicle of delivery is key when looking at achieving effective penetration.

As a consumer, Kazlouskaya understands the interest in the new line.

On an emotional level, I already see myself opening this beautifully designed box containing a classy-looking jar with a massive oak wood cap, she says.

But as a dermatologist, Kazlouskaya is trained to step back and look at the whole package mainly, the evidence behind the ingredients. Thats where shes not sold on the touted benefits of the new line. She says she wants to know:

Wood has similar thoughts. She loves the elegant packaging and the fact that its made from recycled materials. But she cant judge a product by its recycled wine barrel cover.

There is some solid science backing the idea of utilizing plant-derived polyphenols to decrease signs of aging, Wood says. However, more studies need to be conducted on the effectiveness of topical polyphenols and in which vehicles of delivery these molecules will effectively penetrate the epidermis.

Though aging is a natural process that cannot be stopped, experts say some of its effects can be slowed.

Though its not as easy as 1-2-3, Dr. Jeremy Fenton of Schweiger Dermatology Group in NYC has simplified his advice for patients looking for products that help reduce the signs of aging into a three-step process:

1. Sunscreen

2. Retinoid or retinol (if your skin can tolerate it)

3. Topical antioxidant products/serums

The American Academy of Dermatology Association recommends using a broad-spectrum sunscreen of at least SPF 30 or above and reapplying every two hours when exposed to the sun to protect against aging and skin cancer.

Research from 2019 suggests retinoid, a derivative of vitamin A, has skin care benefits, including anti-wrinkle properties.

Fenton says vitamins C and E are two of the antioxidant ingredients found in some serums and products he suggests patients look into.

A 2020 review suggests the use of vitamins C and E could also reduce the signs of aging.

Kazlouskaya agrees about sunscreen, retinol/retinoids, and antioxidants. Though there always seems to be a new ingredient or product on the block, she says less is often more.

I learned to be a minimalist after treating numerous patients with rosacea and sensitive skin, as more does not mean better, she says.

Read the rest here:
Brad Pitt's New Skin Care Line Inspired by Wine: What Experts Think - Healthline

TOP 7 SUPERFOODS TO GAIN WEIGHT IN A HEALTHY WAY – First India

Posted on October 3, 2022 by Danzig

GAIN WEIGHT IN A HEALTHY WAY WITH SUPERFOODS

The key to healthy weight gain lies not only in how much you eat but also in the food choices you make. Eating unhealthy foods such as fries, desserts and junk food would result in an increase in fat mass, not lean muscle. Additionally, it is a sure-shot way to create future health problems like hypertension, elevated cholesterol levels and diabetes. In order to nourish the body as well as gain weight in a healthy manner, incorporate superfoods that are proteinrich, and high in fibre. Foods like nuts, nut butters, whole grains, eggs and cheese pack in a punch of both calories and nutrients and aid in healthy weight gain. However, since they are calorie dense, eating these superfoods in moderation is recommended, or else it will result in obesity and obesity-related ailments. For gaining weight, experts recommend 50% calories from carbohydrates, 25-30% calories from protein and the remaining 20-25 % calories from fats. Along with making the correct food choices, weight lifting exercises are essential for an increase in muscle mass, which is the right way to gain weight.

STARCHY FOODS

Potatoes, sweet potatoes, corn, whole grain bread, oatmeal, whole wheat pasta and brown rice are high-carbohydrate foods with a negligible amount of fats and proteins. They are abundant in vitamins, minerals, fi bre and antioxidants which benefi t other body functions. Along with proteins, carbohydrates are vital for muscle building since carbohydrates have a protein-sparing effect. Carbohydrates stimulate the release of insulin, which pushes amino acids into muscle cells to begin the process of muscle repair. In order to build muscle and gain weight, the body needs both calories and nutrients from these starchy foods. A cup of boiled corn kernels provides 143 calories, 31 grams of carbohydrate and 4 grams of fi bre.

NUTSNuts like walnuts, hazelnuts, almonds, brazil nuts, pistachios and peanuts are some of the most nutrient-dense foods providing nutrients like B complex vitamins, vitamin E, healthy fats and antioxidants. Being high in protein and fi bre, they play a signifi cant role in maintaining stable blood glucose and lipid levels and are one of the best in-between snacking options. About 30 grams of nuts can provide approximately 160 to 190 calories.

PEANUT BUTTERPeanut butter brims with the goodness of healthy fats, vitamin E, fi bre and protein. An excellent source of monounsaturated fatty acids (MUFA) and oleic acid, it boosts HDL (High-Density Lipoprotein) or good cholesterol levels and lowers LDL (LowDensity Lipoprotein) or bad cholesterol levels. Being a good source of skinfriendly nutrients like vitamin E, zinc and magnesium, peanut butter helps maintain smooth and supple skin. Peanut butter also aids muscle mass build-up. A tablespoon of peanut butter provides 94 calories with 8 grams of fat and 4 grams of protein.

CHEESEIn addition to being delicious, cheese is host to a bevvy of nutrients protein, calcium, zinc, vitamin A, vitamin B12 and phosphorus. Being a rich source of calcium, cheese maintains bone health and lowers the risk of osteoporosis. The B-complex vitamins, zinc and vitamin A content in cheese assist in maintaining strong hair and healthy and glowing skin. Cheese contains casein and whey protein that help the body build muscle. A slice of cheddar cheese provides 113 calories along with 9 grams of fat and 7 grams of protein.

DARK CHOCOLATE (70% COCOA OR HIGHER)Dark chocolate improves blood fl ow, prevents the formation of blood clots and maintains a good lipid profi le thus boosting cardiovascular health. Dark chocolate contains phenylethylamine which has a positive effect on mood and cognitive health. The epicatechin and resveratrol compounds in dark chocolate possess antioxidant and anti-infl ammatory properties. With 100 grams providing 546 calories along with 31 grams of fat, dark chocolate can serve as an occasional treat.

EGGSEggs are a powerhouse of protein, zinc, vitamins A, D, B 12, phosphorus and folate. The high biological value of egg protein makes them a perfect post-workout food. Egg yolk is a source of omega-3 fats and choline which boost brain health. Additionally, it contains antioxidants like lutein and zeaxanthin which promote eye health. One large scrambled egg provides 90 calories, 6.7 grams of fat and 6.1 grams of protein.

BREAKFAST CEREALSThe combination of cereals with milk or yoghurt is the perfect way to start the day on a power-packed note with the right blend of carbohydrates, proteins and calcium. It is better to opt for dense, fi bre-rich breakfast cereals such as granola or muesli over fl aky or puffed cereals. Adding dried fruits and nuts like raisins, apricots, walnuts and almonds enhances the nutritional profi le and calorie content signifi cantly.

Go here to see the original:
TOP 7 SUPERFOODS TO GAIN WEIGHT IN A HEALTHY WAY - First India

Home :: National Institute for Biotechnology and Genetic Engineering

Posted on October 3, 2022 by Danzig

Highlights

Events and Activities

NIBGE Email

Welcome to NIBGE

PAEC has clear mandates on the safe use of modern sciences with an aim to improve the socio economic growth of the country. NIBGE is one of the main biotechnology institutes of the four bioscience centers of PAEC and was formally inaugurated by the President of Pakistan in 1994. It is also an affiliate center of ICGEB. The institute is a focal point of modern biotechnology and provides a technology receiving unit to help the development of country through applications of modern biotechnology and genetic engineering. The research programs at NIBGE are mainly aimed at improving agriculture, health, environment and industry and are supported by national and international financial grants. The institute research facilities include state of the art equipments supported by technical services, IT facility and a National Library for Biological Sciences. The institute now offers several services and marketable products. The educational programs leading to MPhil and PhD degrees have also been incorporated in the institutes mandate for the development of human resources in modern sciences.

Announcement

The Worldwide Biotechnology Industry is Expected to Reach $2234 Billion by 2027 – ResearchAndMarkets.com – Business Wire

Posted on October 3, 2022 by Danzig

DUBLIN--(BUSINESS WIRE)--The "Biotechnology Market Research Report by Technology (Cell-based Assays, Chromatography, and DNA Sequencing), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Biotechnology Market size was estimated at USD 876.74 billion in 2021, USD 1,023.15 billion in 2022, and is projected to grow at a CAGR 16.87% to reach USD 2,234.84 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biotechnology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biotechnology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology Market?

4. What is the competitive strategic window for opportunities in the Global Biotechnology Market?

5. What are the technology trends and regulatory frameworks in the Global Biotechnology Market?

6. What is the market share of the leading vendors in the Global Biotechnology Market?

7. What modes and strategic moves are considered suitable for entering the Global Biotechnology Market?

Market Dynamics

Drivers

Restraints

Opportunities

Challenges

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ijpdlj

See the rest here:
The Worldwide Biotechnology Industry is Expected to Reach $2234 Billion by 2027 - ResearchAndMarkets.com - Business Wire

Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology – ETF Trends

Posted on October 3, 2022 by Danzig

Putnam Investments announced that on Friday, September 30, it will launch two new transparent, actively managed, equity exchange traded funds: the Putnam BDC Income ETF (NYSE Arca: PBDC), concentrating on business development companies (BDCs), and the Putnam BioRevolutionETF(NYSE Arca: SYNB), centered on companies operating at the intersection of technology and biology in the biology revolution.

PBDC will represent the first actively managed BDC ETF in the marketplace, investing in a host of BDC opportunities with an eye toward generating income for investors.

Putnam is excited to bring these two dynamic new strategies to market as we seek to address the long-term investment needs of advisors and their clients, said Robert L. Reynolds, president and CEO of Putnam Investments, in a news release. Our firm is focused on providing unique and differentiated offerings delivered through a variety of vehicles that tap Putnams deep investing expertise and exceptional research capabilities.

PBDC invests in exchange traded BDCs based in the U.S. and registered with the SEC. BDCs generally invest in, lend capital to, or provide services to privately held U.S. companies or thinly traded U.S. public companies. Putnam has managed a similar non-public BDC-focused strategy for nearly five years. The fund is managed by Michael Petro.

SYNB, meanwhile, invests in companies that seek to capitalize on the convergence of technological developments in the life sciences sector, including technology-enabling companies, synthetic biology companies, and companies that operate in industries that are likely to benefit from the biology revolution. The fund is managed by William Rives.

We have identified BDCs and advances in the biology sector as providing distinctive opportunities for investors in rapidly evolving sectors of the economy, added Carlo Forcione, head of product and strategy at Putnam Investments. Our new ETFs represent innovative, early-to-market offerings that will align well with the portfolio construction needs of our clients and the broader marketplace.

The new ETFs will join Putnams existing suite of four active ETFs that the firm launched in May 2021: the Putnam Focused Large Cap Growth ETF (NYSE Arca: PGRO), the Putnam Focused Large Cap Value ETF (NYSE Arca: PVAL), the Putnam Sustainable Future ETF (NYSE Arca: PFUT), and the Putnam Sustainable Leaders ETF (NYSE Arca: PLDR).

For more news, information, and strategy, visitVettaFi.

Read the rest here:
Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology - ETF Trends

Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors – GlobeNewswire

Posted on October 3, 2022 by Danzig

Press release

Cambridge, MA U.S.A. (September 26, 2022) Allarity Therapeutics, Inc. (Nasdaq: ALLR) (Allarity or the Company), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP companion diagnostics for personalized cancer care, today announced the appointment of Jerry McLaughlin as a new member of its Board of Directors, effective October 1, 2022.

Mr. McLaughlin is a highly accomplished biotechnology executive with extensive experience in financing, drug development, licensing, commercialization, and product lifecycle management. Mr. McLaughlin is expected to serve on the compensation, and audit committees as an independent director.

I am delighted that Jerry has chosen to join Allaritys board at this crucial time in our evolution, said Dr. Duncan Moore, Allaritys Chairman of the Board. His operational experience in clinical stage therapeutic development and capital markets acumen will be of great value as we continue to implement the Companys combination therapy-focused strategy.

Mr. McLaughlin said: I firmly believe Allarity Therapeutics is in a unique position to become a leader within the personalized medicine space by developing novel combination oncology therapies together with the Companys unique DRP companion diagnostics. Allaritys recent strategic shift is aligned with the ongoing patient and market realities in oncology, as we continue to see substantially higher patient benefits with combination therapies. I look forward to supporting the CEO, Jim Cullem, and the rest of the Allarity team in unlocking both the clinical and commercial potential of this strategy.

Mr. McLaughlin has three decades of experience in leading operational and executive management roles. He made key contributions to significant life science milestones, including product launches, acquisitions, and financings. He is currently serving as CEO and Board Member of Life Biosciences, LLC, a development-stage biopharmaceutical company advancing therapeutics for patients with neurological and psychiatric diseases. Prior to serving in this role, he was President, CEO, and Member of the Board of Directors at Neos Therapeutics (acquired by Aytu BioScience.) Before joining Neos Therapeutics, he served as President, CEO, and Member of the Board of Directors at AgeneBio, Inc. Earlier in his career, he held corporate leadership roles at NuPathe, Inc., Endo Pharmaceuticals Inc., and Merck & Co., Inc. He received his B.A. from Dickinson College and his MBA from Villanova University in Pennsylvania.

About Allarity Therapeutics

Allarity Therapeutics, Inc. (Nasdaq: ALLR) develops drugs for personalized treatment of cancer guided by its proprietary and highly validated companion diagnostic technology, the DRP platform. The Company has a mature portfolio of three drug candidates: stenoparib, a PARP inhibitor in Phase 2 development for ovarian cancer; dovitinib, a post-Phase 3 pan-tyrosine kinase inhibitor; and the European rights to IXEMPRA (Ixabepilone), a microtubule inhibitor approved in the U.S. and marketed by R-PHARM U.S. for the treatment of second-line metastatic breast cancer, currently in Phase 2 development in Europe for the same indication. Additionally, the Company has rights in two secondary assets: 2X-111, a liposomal formulation of doxorubicin in Phase 2 development for metastatic breast cancer and/or glioblastoma multiforme (GBM), which is the subject of discussions for a restructured out-license to Smerud Medical Research International AS; and LiPlaCis, a liposomal formulation of cisplatin and its accompanying DRP, being developed via a partnership with Chosa ApS, an affiliate of Smerud Medical Research International, for late-stage metastatic breast cancer. The Company is headquartered in the United States and maintains an R&D facility in Hoersholm, Denmark. For more information, please visit the Companys website at http://www.Allarity.com.

About the Drug Response Predictor DRP Companion Diagnostic

Allarity uses its drug-specific DRP to select those patients who, by the genetic signature of their cancer, are found to have a high likelihood of responding to the specific drug. By screening patients before treatment, and only treating those patients with a sufficiently high DRP score, the therapeutic response rate can be significantly increased. The DRP method builds on the comparison of sensitive vs. resistant human cancer cell lines, including transcriptomic information from cell lines combined with clinical tumor biology filters and prior clinical trial outcomes. DRP is based on messenger RNA from patient biopsies. The DRP platform has proven its ability to provide a statistically significant prediction of the clinical outcome from drug treatment in cancer patients in 37 out of 47 clinical studies that were examined (both retrospective and prospective), including ongoing, prospective Phase 2 trials of Stenoparib and IXEMPRA. The DRP platform, which can be used in all cancer types and is patented for more than 70 anti-cancer drugs, has been extensively published in peer reviewed literature.

Follow Allarity on Social Media

Facebook: https://www.facebook.com/AllarityTx/ LinkedIn: https://www.linkedin.com/company/allaritytx/ Twitter: https://twitter.com/allaritytx

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide Allaritys current expectations or forecasts of future events. The words anticipates, believe, continue, could, estimate, expect, intends, may, might, plan, possible, potential, predicts, project, should, would and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements related to clinical and commercial potential due to the Company advancing dovitinib in combination with another therapeutic candidate or other approved drug, any statements related to ongoing clinical trials for stenoparib as a monotherapy or in combination with another therapeutic candidate for the treatment of advanced ovarian cancer, or ongoing clinical trials (in Europe) for IXEMPRA for the treatment of metastatic breast cancer, and statements relating to the effectiveness of the Companys DRP companion diagnostics platform in predicting whether a particular patient is likely to respond to a specific drug. Any forward-looking statements in this press release are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to,the risk that results of a clinical study do not necessarily predict final results and that one or more of the clinical outcomes may materially change following more comprehensive reviews of the data, and as more patient data become available, the risk that results of a clinical study are subject to interpretation and additional analyses may be needed and/or may contradict such results, the receipt of regulatory approval for dovitinib or any of our other therapeutic candidates or, if approved, the successful commercialization of such products, the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies will not be repeated or observed in ongoing or future studies involving our therapeutic candidates, and the risk that the current COVID-19 pandemic will impact the Companys current and future clinical trials and the timing of the Companys preclinical studies and other operations. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled Risk Factors in our Form S-1 registration statementon file with theSecurities and Exchange Commission, available at the Securities and Exchange Commissions website atwww.sec.gov, and as well as discussions of potential risks, uncertainties and other important factors in the Companys subsequent filings with theSecurities and Exchange Commission. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.

###

Company Contact:

Thomas JensenSenior V.P. of Investor Relationsinvestorrelations@allarity.com

Investor Relations:

Chuck PadalaLifeSci Advisors+1(646) 627-8390chuck@lifesciadvisors.comU.S. Media Contact:

Mike Beyer Sam Brown, Inc. +1 (312) 961-2502 mikebeyer@sambrown.com

EU Media Contact:

Thomas PedersenCarrotize PR & Communications +45 6062 9390tsp@carrotize.com

Read the rest here:
Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors - GlobeNewswire

The Best Biotechnology Stocks to Invest in Right Now – Best Stocks

Posted on October 3, 2022 by Danzig

Image Source: FreeImages

The global bio-economy is growing at an incredible pace, with plenty of opportunity for investors. The biotech industry in general, and biotech stocks specifically, provide a lot of potential for long-term returns. Biotechnology is the application of biological principles to create new products and services. It has many applications, from agricultural uses to medical research and drug development. As a result, the biotechnology sector has grown strongly as other industries adopt its technologies and invest in related ventures and partnerships.Investors looking to capitalize on this growth need to understand which companies are leading the way. Fortunately, there are several great biotechnology stocks that can offer excellent returns in the coming years. Here are some of the top opportunities currently available:

Global Blood Therapeutics (GBT) is an emerging biotechnology company focused on creating therapies for rare blood diseases.GBTs lead product, Prophage, is a gene therapy designed to treat patients with beta-thalassemia, a rare inherited blood disorder.drug has been granted Orphan Drug Designation by the FDA and designation as a Breakthrough Therapy from the FDAs Oncology Drug Review Committee.GBT has also partnered with Galapagos NV, one of the top gene-therapy companies in the world. The company has a Phase 3 development program for Prophage, with a goal to complete registration in the next few years. With a potential blockbuster drug on the table, GBT has the potential to grow very quickly.

BridgeBio Pharma (BBIO) is a clinical-stage biopharmaceutical company focused on bringing new therapies to patients suffering from rare diseases.BBIO has a robust product pipeline, with several therapies in Phase 1 and 2 clinical trials. The company is also in the pre-clinical development stages of several promising new therapies. BBIOs main product candidates are focused on iron-related disorders, including an iron chelating agent for patients with rare blood diseases.BBIO has partnered with some of the largest companies in the world, including The Medicines Company, Celgene, and Bayer.BBIOs therapies are currently in Phase 2 development and are expected to advance into Phase 3 in the next few years. When these drugs are approved, BBIO will be poised for growth.

SIGA Technologies (SIGA) is a biopharmaceutical company focused on creating vaccines and medicines for infectious diseases.SIGA has a robust product pipeline focused on viral diseases, including respiratory and viral hemorrhagic fever diseases. The company is currently investing in three main products.First is a universal flu vaccine designed to address issues with current flu vaccines. SIGAs universal flu vaccine is administered as a nasal spray, has no adjuvant, and is designed to provide constant immunity to the most common flu strains.Second is an Ebola vaccine designed to treat patients infected with the Ebola virus. The vaccine has been in development since 2003, when the Ebola outbreak in Africa began.Third is a therapeutic vaccine designed to treat dengue fever. The vaccine has completed Phase 1/2 trials and is expected to advance into Phase 3 trials in the next few years.

Ninety (NOVT) is a biotechnology company focused on creating therapies for the eye.NOVT is currently developing a first-in-kind therapy called a corneal scarring therapy that could replace corneal transplants in some patients.The company is expected to advance this product into Phase 3 trials in the next few years. Once the treatment is approved, it could become a huge product for NOVT.While the companys main product remains in development, it is also investing in other eye-related therapies. NOVT has a partnership with Galapagos NV to develop gene therapies for retinal diseases. The company is also developing a novel combination therapy for glaucoma.

Biotechnology is a growing industry that is expected to continue to see strong growth. The sector is also expected to see some strong mergers and acquisitions, providing another avenue for growth.Investors looking for growth in the biotechnology industry can consider investing in any of the top biotechnology stocks above. These companies are all poised for growth over the next several years, and could offer excellent returns for investors.

Image Source: FreeImages

The global economy is growing incredibly, with plenty of opportunities for investors. The biotech industry, in general, and biotech stocks, provide a lot of potential for long-term returns. Biotechnology is the application of biological principles to create new products and services. It has many applications, from agricultural uses to medical research and drug development. As a result, biotechnology has grown strongly as other industries adopt its technologies and invest in related ventures and partnerships. Investors looking to capitalize on this growth need to understand which companies are leading the way. Fortunately, several great biotechnology stocks can offer excellent returns in the coming years. Here are some of the top opportunities currently available:

Global Blood Therapeutics (GBT) is an emerging biotechnology company focused on creating therapies for rare blood diseases.GBTs lead product, Prophage, is a gene therapy designed to treat patients with beta-thalassemia, a rare inherited blood disorder. The drug has been granted Orphan Drug Designation by the FDA and designated as a Breakthrough Therapy by the FDAs Oncology Drug Review Committee.GBT has also partnered with Galapagos NV, one of the top gene-therapy companies in the world. In addition, the company has a Phase 3 development program for Prophage, to complete registration in the next few years. With a potential blockbuster drug on the table, GBT has the potential to grow very quickly.

SIGA Technologies (SIGA) is a biopharmaceutical company focused on creating vaccines and medicines for infectious diseases.SIGAs robust product pipeline focused on viral diseases, including respiratory and viral hemorrhagic fever. The company is currently investing in three main products:

The vaccine has completed Phase 1/2 trials and is expected to advance into Phase 3 trials in the next few years.

Ninety (NOVT) is a biotechnology company focused on creating therapies for the eye.NOVT is currently developing a first-in-kind therapy called corneal scarring therapy that could replace corneal transplants in some patients. The company is expected to advance this product into Phase 3 trials in the next few years. Once approved, the treatment could become a huge product for NOVT. While the companys main product remains developing, it is also investing in other eye-related therapies. For example, NOVT partnered with Galapagos NV to develop gene therapies for retinal diseases. In addition, the company is also developing a novel combination therapy for glaucoma.

Biotechnology is a growing industry that is expected to continue to see strong growth. The sector is also expected to see strong mergers and acquisitions, providing another avenue for growth. Investors looking for growth in the biotechnology industry can consider investing in any of the top biotechnology stocks above. These companies are poised for growth over the next several years and could offer excellent returns for investors.

View post:
The Best Biotechnology Stocks to Invest in Right Now - Best Stocks

Viewpoint: Will King Charles abandon his kooky ideas about agriculture and help accelerate Britain’s embrace of sustainable biotechnology tools? -…

Posted on October 3, 2022 by Danzig

England is in crisis. They lost a beloved figurehead this month but for decades prior were losing scientific ground. If you look for the home of the modern organic food and anti-vaccine movements, you find their nexus in 1990s England.

The primary royal behind those beliefs is now King Charles III.

In order to manage the $28 billion he inherits (tax-free, paying taxes only applies to peasants in England)(1) he will have to give his $1.5 billion estate to his son, the new Prince of Wales, William (also tax free) but the Prince is not only taking over during a time when Brits are wondering why they still care about a throne that hasnt been relevant in hundreds of years, he is taking over at a time when being anti-science is no longer fashionable for progressive elites.

Though it was recently the darling of the intelligentsia, and Prince Charles longed to belong in that circle, anti-vaccine sentiments have become proletariat since COVID-19. The war on science when it comes to food harms a lot more people worldwide each year than the pandemic did. Hundreds of thousands of kids could stop going blind each year with Golden Rice but elites like King Charles III give money to groups that block its implementation.

Prince William could start to gain back some credibility for the family by jettisoning the organic food fetish of his father. Organic food, like the anti-vaccine movement, is a relic of 1990s England. Dr. Andrew Wakefield set off the modern anti-vaccine craze the same way that English environmental activists set off the Frankenfood one. Now supplements, wellness, and organic are all giant businesses based on exploitation of famous names who wanted to impress their elite friends

The world should have passed the anti-vaccine and anti-food movement by but they persist in large part because of the new British monarch and his quasi-American royalty of American Democrats counterpart, Robert F. Kennedy, Jr.(2)

Its easy to embrace science, especially in light of their history making changes when it was needed. They changed their name to Windsor from Saxe-Coburg and Gotha during World War I to help commoners forget the British royal family is German during a time that Germany was shooting at English men in Europe. Given that public relations success, they can certainly change their tune when it comes to science.

Perhaps due to an infusion of new blood outside the shockingly limited pool drawn from during the 19th and 20th centuries, Prince William seems to be a more genetically gifted thinker than his father. He can show it by embracing the modern world, where food and medicine are embraced.(3)

He doesnt actually have to divest from the farm, that is just me getting attention in a title. It is enough if he acknowledges that having peasants toil for his carrots only using specially labeled toxic pesticides is a pastime for the rich, and not a way to feed the world.

(1) The same way California Governor Gavin Newsom doesnt want people who make over $2 million each year to pay higher taxes to subsidize the electric cars the Governor insists Uber drivers need to buy. High taxes are for the middle class and the poor, not the donors he will need in order to fail running for President in 2024.

(2) Nothing looks more hypocritical than people on the left in England and the US suddenly endorsing vaccines when just two years ago they opposed them. It instead reeks of politics, and politics need to be a no-no for the new generation of British royals, lest they be relegated to the name recognition of the Queen of the Netherlands, whoever that is.

(3) and not just engage in publicity stunts about energy costs that are squarely the blame of the government his father now seeks to lead.

Hank Campbell founded Science 2.0 in 2006, and writes for USA Today, Wall Street Journal, CNN, and more. His first book,Science Left Behind,was the #1 bestseller on Amazon for environmental policy books. Follow Hank on Twitter@HankCampbell

A version of this article was originally posted atScience 2.0and is reposted here with permission. Science 2.0 can be found on Twitter@science2_0

Visit link:
Viewpoint: Will King Charles abandon his kooky ideas about agriculture and help accelerate Britain's embrace of sustainable biotechnology tools? -...

China’s Syngenta pushes the edge: Can technology-driven agriculture promote a new view of sustainable farming to a world still wary of biotechnology?…

Posted on October 3, 2022 by Danzig

China has very small farms; there hasnt been a lot of infrastructure put in place in terms of knowledge or solid assets. Now Syngenta is enabling them with agronomists and digital infrastructure.

When it comes to Beijings technological ambitions, high profile hardware like semiconductors and electric vehicles tend to dominate global headlines. But in China, where almost 20 percent of the global population lives on 8.5 percent of the worlds arable land, finding innovative ways to reap more food from every hectare of seeds sown has long been one of the governments highest priorities.

Chinese agriculture and food demand is in inherent conflict, says Wendong Zhang, an assistant professor at Cornell Universitys Dyson School of Applied Economics and Management and a specialist in Chinas agricultural development. China wont be able to have more land. They wont be able to have better quality soil. The thing they can control is technology.

Beijings realization that technology would be key to increasing its food self-sufficiency is what made Syngenta such a valuable target for ChemChina. Syngenta, after all, is the world-leader in crop protection products and globally the number three producer of seeds, including selectively-bred hybrids and genetically modified seeds. Alongside rivals like Germanys Bayer and Americas Corteva (formerly DowDupont), the company is pushing the boundaries of seed genomics using CRISPR-Cas9, a tool that allows researchers to tweak the genetics of living organisms.

Emboldened by its ownership of Syngenta, China seems to be crossing the rubicon when it comes to high-tech agriculture. Officials are now calling cutting-edge seeds agriculture microchips, according to Chinese state media.

And safety approvals for GM seeds appear to be speeding up: in early 2022, Beijings Ministry of Agriculture and Rural Affairs (MARA) granted safety certificates to three Syngenta GM corn seeds as well as a seed from the domestic firm Hangzhou Ruifeng Bio-Tech Company and several others from Chinese universities. In June, MARA also released guidelines, for the first time, that could pave the way for companies to begin commercial planting of GM products.

And with its high-profile Shanghai listing, Syngenta might help the Chinese government out of a dilemma of its own making: convincing the general public that GMOs are safe. At the very least, the company cant be viewed as a trojan horse for U.S. bioweapons. Syngentas MAP program has even introduced QR codes on food packaging so consumers can scan their food and see a photo of the Chinese farmer who grew it.

To help itself out of its GMO bind, Beijing is also positioning its efforts in direct gene editing as a kind of technological leapfrogging these newer engineering methods do not require the introduction of foreign DNA, unlike todays genetic modification, in which bacteria from one organism is transplanted into another ( la the Bt genes added into the corn genome). As [Shane] Thomas, the analyst, notes, the industry as a whole is moving towards this more precise kind of genetic tweaking.

This is an excerpt. Read the original post here

Nanoparticles in Biotechnology and Pharmaceuticals Market Size And Forecast To 2022 |Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals The…

Posted on October 3, 2022 by Danzig

Los Angeles, USA: A recent report published by Verified Market Research, titled [Global Nanoparticles in Biotechnology and Pharmaceuticals Market, History and Forecasts for 2022-2029, data broken down by manufacturers, key regions, types and applications], contains an in-depth analysis of the Global Nanoparticles in Biotechnology and Pharmaceuticals Market. The research report is divided in such a way as to highlight the key areas of the market and give the reader a complete picture. The report examines various aspects of the Nanoparticles in Biotechnology and Pharmaceuticals market, such as its opportunities to explore its driving forces and limitations, market size, market segment analysis, regional prospects, key players and the competitive environment. Market Research Report Nanoparticles in Biotechnology and Pharmaceuticals uses the methodology of primary and secondary research to provide accurate data to its readers. To fully assess the market and key players. Analysts also used SWOT analysis and analysis of Porters five strengths.

In the Global Nanoparticles in Biotechnology and Pharmaceuticals Market, analysts provided historical and forecast data on the market, as well as the expected growth of average annual indicators. This will help the reader to evaluate the market in terms of its growth.

Nanoparticles in Biotechnology and Pharmaceuticals Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027.

Get a Sample Copy (Including FULL TOC, Graphs And Tables) Of This Report @ https://www.verifiedmarketresearch.com/download-sample?rid=19246

Global Nanoparticles in Biotechnology and Pharmaceuticals Market : Drivers and Restraints

In this chapter, the report provides a full explanation of the driving forces of the market. It highlights the main driving forces of the market, which are expected to make a significant contribution to the growth of the market. It covers various industries that are developing in the same field, identifies the main areas of application and determines which of them will play an important role. The report also examines some of the new technologies and developments presented by manufacturers that are expected to become notable engines for the global Nanoparticles in Biotechnology and Pharmaceuticals market.

This chapter also gives the reader important information regarding restrictions that may hinder the growth of the Nanoparticles in Biotechnology and Pharmaceuticals market in the future. This research report discussed factors such as changes in land prices, labor and production costs, environmental issues, new government policies and business standards. In addition, the analysts also gave an idea of the potential opportunities existing in the global market of Nanoparticles in Biotechnology and Pharmaceuticals. It offers a new perspective of turning threats into viable options to give the company a chance to win.

Global Nanoparticles in Biotechnology and Pharmaceuticals Market : Competitive rivalry

The research report includes an analysis of the competitive environment present in the Global Nanoparticles in Biotechnology and Pharmaceuticals Market. It includes an assessment of current and future trends in which players can invest. In addition, it also includes an assessment of the financial prospects of the players and explains the nature of the competition.

Key Players mentioned in the Global Market Research Report Nanoparticles in Biotechnology and Pharmaceuticals Market:

Market segmentation of Nanoparticles in Biotechnology and Pharmaceuticals market:

Nanoparticles in Biotechnology and Pharmaceuticals market is divided by type and application. For the period 2021-2028, cross-segment growth provides accurate calculations and forecasts of sales by Type and Application in terms of volume and value. This analysis can help you grow your business by targeting qualified niche markets.

Nanoparticles in Biotechnology and Pharmaceuticals Market by Product

Fullerenes Liquid Crystals Liposomes Nanoshells Quantum dots Superparamagnetic nanoparticles

Nanoparticles in Biotechnology and Pharmaceuticals Market by Application

Biotechnology Pharmaceutical

Get Exclusive Discount on this Premium Report @ https://www.verifiedmarketresearch.com/ask-for-discount?rid=19246

Nanoparticles in Biotechnology and Pharmaceuticals Market Report Scope

Global Nanoparticles in Biotechnology and Pharmaceuticals Market: Regional segmentation

For further understanding, the research report includes a geographical segmentation of the Global Nanoparticles in Biotechnology and Pharmaceuticals Market. It provides an assessment of the volatility of political scenarios and changes that may be made to regulatory structures. This estimate provides an accurate analysis of the regional growth of the Global Nanoparticles in Biotechnology and Pharmaceuticals Market.

Middle East and Africa (GCC countries and Egypt)North America (USA, Mexico and Canada)South America (Brazil, etc.)Europe (Turkey, Germany, Russia, Great Britain, Italy, France, etc.)Asia-Pacific region (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Global Nanoparticles in Biotechnology and Pharmaceuticals Market: Research methodology

The research methodologies used by analysts play a crucial role in how the publication was compiled. Analysts used primary and secondary research methodologies to create a comprehensive analysis. For an accurate and accurate analysis of the Global Nanoparticles in Biotechnology and Pharmaceuticals Market, analysts use ascending and descending approaches.

Table of Contents

Report Overview:It includes major players of the global Nanoparticles in Biotechnology and Pharmaceuticals Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Nanoparticles in Biotechnology and Pharmaceuticals Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Nanoparticles in Biotechnology and Pharmaceuticals Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Nanoparticles in Biotechnology and Pharmaceuticals Market by application, it gives a study on the consumption in the global Nanoparticles in Biotechnology and Pharmaceuticals Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Nanoparticles in Biotechnology and Pharmaceuticals Market are profiled in this section. The analysts have provided information about their recent developments in the global Nanoparticles in Biotechnology and Pharmaceuticals Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Nanoparticles in Biotechnology and Pharmaceuticals Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Nanoparticles in Biotechnology and Pharmaceuticals Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Nanoparticles in Biotechnology and Pharmaceuticals Market.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report @https://www.verifiedmarketresearch.com/product/nanoparticles-in-biotechnology-and-pharmaceuticals-market/

Visualize Anesthesia Delivery Systems Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

Visualize Anesthesia Delivery Systems Market using VMI @https://www.verifiedmarketresearch.com/vmintelligence/

About us

Verified Market Research is the Globals leading research and consulting firm serving more than 5,000 clients. Verified market research provides advanced analytical research solutions, offering research enriched with information. We offer information about strategic analysis and growth, data needed to achieve business goals, and important revenue decisions.

Our 250 analysts and representatives of small and medium-sized businesses have a high level of knowledge in the field of data collection and management. They use industrial methods to collect and analyze data in more than 15,000 highly efficient niches and markets. Our analysts are trained to combine modern data collection methods, excellent research methodologies, years of collective experience and expertise to conduct informative and accurate research.

We study more than 14 categories of semiconductors and electronics, chemicals, advanced materials, aerospace and defense industries, energy and consumables, healthcare, pharmaceuticals, Automotive and Transportation, Information and Communication Technologies, software and services, information security, mining, minerals and metals, construction, agricultural industry and medical equipment from in more than 100 countries.

Dwayne Fernandez

Verified Market ResearchABOUT US: +1 (650)-781-4080United Kingdom: +44 (753)-715-0008APAC: +61 (488)-85-9400Free in the United States.: +1 (800)-782-1768

See the rest here:
Nanoparticles in Biotechnology and Pharmaceuticals Market Size And Forecast To 2022 |Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals The...

Future Markets Research Releases Commentary on NurExone Biologic Inc, An Emerging Leader in The Exos – PharmiWeb.com

Posted on October 3, 2022 by Danzig

Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.

ABOUT THIRD PARTY LINKS ON OUR SITE

PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com.

PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.

Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely.

If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.

More here:
Future Markets Research Releases Commentary on NurExone Biologic Inc, An Emerging Leader in The Exos - PharmiWeb.com

Tribulus Terrestris Extract Market Demand With Future Forecast Green Labs, BioTae, Nutra Green Biotechnology, JIAHERB The Colby Echo News – The…

Posted on October 3, 2022 by Danzig

The Global Tribulus Terrestris Extract Market study report consists the data about overall revenue & sales during the forecast period of 2022 to 2028. The objective of MarketQuest.biz is to offer a complete picture of the market to the customers and assist them in creating increased techniques. The potential growth likelihoods along with the penetration rate analysis of the Tribulus Terrestris Extract market are included in the report to understand the adoption rate and formulate strategies likewise.

The report also provides a comprehensive picture of the Tribulus Terrestris Extract market by synthesizing, summating, and studying data from various sources by examining key parameters like promotions, profit, pricing, and competition. The market estimates have been evaluated by considering the effect of different social, political, economic, legal, and technological factors, based on extensive primary research, secondary research, and in-house databases.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/103606

Moreover, the markets total volume of sales and marketing, the overall amount of production & consumption, in-depth price analysis, profit margins, export, import, vendor landscapes, competitive landscape analysis, and key factors for accurate market appraisal are all well-combined. The report provides a year-to-year growth of the market for the user to be primarily aware of the changing scenario of the global Tribulus Terrestris Extract market.

Some of the most promising players include:

Based on product type, global Tribulus Terrestris Extract market research report:

On the basis of the applications, Tribulus Terrestris Extract market research report:

ACCESS FULL REPORT: https://www.marketquest.biz/report/103606/global-tribulus-terrestris-extract-market-2022-by-manufacturers-regions-type-and-application-forecast-to-2028

The study by geography highlights the consumption of the product/service in the region and indicates the factors affecting Tribulus Terrestris Extract market within each region:

Read this article:
Tribulus Terrestris Extract Market Demand With Future Forecast Green Labs, BioTae, Nutra Green Biotechnology, JIAHERB The Colby Echo News - The...

Futurist Transhuman News Blog

Monthly Archives: October 2022

How to Watch ‘Interview With The Vampire’ Series Premiere For Free on Apple TV, Roku, Fire TV and Mobile – The Streamable

A Young Kobe Bryant Once Made 9 Players On The Court Cry While Playing In Italy: "The Other 9 Players Started Crying And Their Parents Started…

Baijnath: The Himachal town that doesn’t celebrate Dussehra – Times of India

Legacy of Kain series revival teased by Crystal Dynamics in new survey – Niche Gamer

Star Wars’ Darth Vader will ‘live forever’ after being given digital AI immortality – Daily Star

Pop the cork to unlock the health benefits of red wine – Lifestyle Asia India

Peanuts: Best guide to learn health benefits, nutrition and side effects – PINKVILLA

What 6 Over-50 Beauty Experts Do to Treat Their Own Skin – NewBeauty Magazine

Brad Pitt’s New Skin Care Line Inspired by Wine: What Experts Think – Healthline

TOP 7 SUPERFOODS TO GAIN WEIGHT IN A HEALTHY WAY – First India

Home :: National Institute for Biotechnology and Genetic Engineering

The Worldwide Biotechnology Industry is Expected to Reach $2234 Billion by 2027 – ResearchAndMarkets.com – Business Wire

Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology – ETF Trends

Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors – GlobeNewswire

The Best Biotechnology Stocks to Invest in Right Now – Best Stocks

Viewpoint: Will King Charles abandon his kooky ideas about agriculture and help accelerate Britain’s embrace of sustainable biotechnology tools? -…

China’s Syngenta pushes the edge: Can technology-driven agriculture promote a new view of sustainable farming to a world still wary of biotechnology?…

Nanoparticles in Biotechnology and Pharmaceuticals Market Size And Forecast To 2022 |Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals The…

Future Markets Research Releases Commentary on NurExone Biologic Inc, An Emerging Leader in The Exos – PharmiWeb.com

Tribulus Terrestris Extract Market Demand With Future Forecast Green Labs, BioTae, Nutra Green Biotechnology, JIAHERB The Colby Echo News – The…